Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangeetha M Reddy

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cells|June 2, 2021
Mast Cells: A New Frontier for Cancer ImmunotherapyJake N Lichterman, Sangeetha M Reddy
Expert Review of Anticancer Therapy|February 19, 2020
Atezolizumab for the treatment of breast cancerSangeetha M Reddy, Emma Carroll, Rita Nanda
Current Oncology Reports|May 25, 2016
Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted TherapySangeetha M Reddy, Alexandre Reuben, Jennifer A Wargo
Current Opinion in Immunology|May 31, 2016
Monitoring immune responses in the tumor microenvironmentJennifer A Wargo, Sangeetha M Reddy, Alexandre Reuben, et al.
Cancer|May 26, 2017
Interaction of molecular alterations with immune response in melanomaRobert A Szczepaniak Sloane, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, et al.
Breast Cancer Research and Treatment|June 26, 2026
Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimenRiya Albert, Joshua Thomas, Navid Sadeghi, et al.
Journal for Immunotherapy of Cancer|May 25, 2023
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responsesAmrendra Kumar, Vijay Ramani, Vijaya Bharti, et al.
Clinical Colorectal Cancer|September 5, 2015
Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal MalignanciesSangeetha M Reddy, Maxwell T Vergo, Judith A Paice, et al.
Journal of Visualized Experiments : Jove|November 28, 2022
Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without PassagingSerena L Cornelius, Megan M Colonnetta, Katherine E Lake, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Organoid generation from mouse mammary tumors captures the genetic heterogeneity of clinically relevant copy number alterationsKatherine E Lake, Megan M Colonetta, Clayton A Smith, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cells|June 2, 2021
Mast Cells: A New Frontier for Cancer ImmunotherapyJake N Lichterman, Sangeetha M Reddy
Expert Review of Anticancer Therapy|February 19, 2020
Atezolizumab for the treatment of breast cancerSangeetha M Reddy, Emma Carroll, Rita Nanda
Current Oncology Reports|May 25, 2016
Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted TherapySangeetha M Reddy, Alexandre Reuben, Jennifer A Wargo
Current Opinion in Immunology|May 31, 2016
Monitoring immune responses in the tumor microenvironmentJennifer A Wargo, Sangeetha M Reddy, Alexandre Reuben, et al.
Cancer|May 26, 2017
Interaction of molecular alterations with immune response in melanomaRobert A Szczepaniak Sloane, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, et al.
Breast Cancer Research and Treatment|June 26, 2026
Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimenRiya Albert, Joshua Thomas, Navid Sadeghi, et al.
Journal for Immunotherapy of Cancer|May 25, 2023
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responsesAmrendra Kumar, Vijay Ramani, Vijaya Bharti, et al.
Clinical Colorectal Cancer|September 5, 2015
Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal MalignanciesSangeetha M Reddy, Maxwell T Vergo, Judith A Paice, et al.
Journal of Visualized Experiments : Jove|November 28, 2022
Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without PassagingSerena L Cornelius, Megan M Colonnetta, Katherine E Lake, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Organoid generation from mouse mammary tumors captures the genetic heterogeneity of clinically relevant copy number alterationsKatherine E Lake, Megan M Colonetta, Clayton A Smith, et al.
Pageof 3